Correlation Between Amexdrug and Cannabis One
Can any of the company-specific risk be diversified away by investing in both Amexdrug and Cannabis One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amexdrug and Cannabis One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amexdrug and Cannabis One Holdings, you can compare the effects of market volatilities on Amexdrug and Cannabis One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amexdrug with a short position of Cannabis One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amexdrug and Cannabis One.
Diversification Opportunities for Amexdrug and Cannabis One
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Amexdrug and Cannabis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Amexdrug and Cannabis One Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis One Holdings and Amexdrug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amexdrug are associated (or correlated) with Cannabis One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis One Holdings has no effect on the direction of Amexdrug i.e., Amexdrug and Cannabis One go up and down completely randomly.
Pair Corralation between Amexdrug and Cannabis One
If you would invest 0.00 in Cannabis One Holdings on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Cannabis One Holdings or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Amexdrug vs. Cannabis One Holdings
Performance |
Timeline |
Amexdrug |
Cannabis One Holdings |
Amexdrug and Cannabis One Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amexdrug and Cannabis One
The main advantage of trading using opposite Amexdrug and Cannabis One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amexdrug position performs unexpectedly, Cannabis One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis One will offset losses from the drop in Cannabis One's long position.Amexdrug vs. Tower Semiconductor | Amexdrug vs. MagnaChip Semiconductor | Amexdrug vs. Elmos Semiconductor SE | Amexdrug vs. Maanshan Iron Steel |
Cannabis One vs. Holloman Energy Corp | Cannabis One vs. cbdMD Inc | Cannabis One vs. Evolus Inc | Cannabis One vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
CEOs Directory Screen CEOs from public companies around the world |